New Delhi, Dec 23 (IANS) The Centre on Friday approved Bharat Biotech’s needle-free intranasal Covid vaccine for booster dose, said an official source. The nassal vaccine has been approved for those aged above 18 years. The vaccine will be available in
Hyderabad, Nov 29 (IANS) Leading vaccine maker, Bharat Biotech International Limited (BBIL) on Monday announced that world’s first intranasal vaccine for Covid-19, iNCOVACC (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency Situation
Bengaluru, Oct 14 (IANS) Covaxin maker Dr. Krishna M. Ella has evinced interest in investing in Karnataka. Ella, Chairman and MD of Bharat Biotech, which produces Covaxin, met state Minister for Large and Medium Industries Dr. Murugesh R. Nirani, in Hyderabad
Hyderabad, Sep 7 (IANS) Bharat Biotech’s iNCOVACC, the world’s first intranasal vaccine for Covid-19 which received approval for emergency use in India on Tuesday, will be a global game changer in intranasal vaccines technology and delivery systems, the vaccine maker’s Chairman
New Delhi, Aug 16 (IANS) Hyderabad-based vaccine manufacturer Bharat Biotech on Monday said it has completed the clinical development for phase 3 trials and booster doses for India’s first intranasal Covid vaccine — BBV154. The vaccine manufacturer said that BBV154 (intra
Hyderabad, Aug 15 (IANS) Vaccine-maker Bharat Biotech announced on Monday that its intranasal vaccine for Covid-19 has been proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials. The Hyderabad-based company completed clinical development for phase III trials
Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population. New Delhi, May 5 (IANS) Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of
Ocugen, a biotechnology company focused on discovering, developing, and commercialising novel gene therapies, biologicals and vaccines, and Bharat Biotech, announced that they have entered into an amendment to their agreement to expand Ocugen’s exclusive territory to include commercialisation of Covaxin
After the World Health Organisation (WHO) suspended the supply of Bharat Biotech’s Covaxin vaccine under the United Nations (UN) procurement after an inspection last month, the company has said it is working on upgrades to ensure that the production of
New Delhi, Jan 20 (IANS) India’s two main vaccines — Bharat Biotechs Covaxin and Serum Institute of India’s Covishield — on Wednesday got the nod for regular market authorisation. An expert panel of Central Drugs Standard Control Organisation (CDSCO) — India’s
Hyderabad, Jan 19 (IANS) Bharat Biotech has urged healthcare workers to ensure that only Covaxin is administered to individuals in the 15-18 years age group. The Hyderabad-based vaccine maker on Tuesday said that it “received several additional reports of individuals in
Hyderabad, Dec 28 (IANS) Bharat Biotech is targeting to make one billion doses of its Covid-19 intranasal vaccine annually while it is on track to achieve one billion doses of Covaxin, India’s first indigenous Covid vaccine. The Hyderabad-based vaccine maker has
Hyderabad, Dec 21 (IANS) Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to conduct Phase 3 trials of its Covid-19 intranasal vaccine, sources said on Monday. The Hyderabad-based vaccine maker has submitted the application and
Hyderabad, Dec 20 (IANS) An opened vial of Covid-19 vaccine Covaxin can be stored at 2 to 8 degrees Celsius for up to 28 days and is not required to be discarded immediately in a day or at the end of
New Delhi, Dec 17 On the occasion of the official visit to the Republic of India from December 15 to 19, 2021 of Vuong Dinh Hue, President of the National Assembly at the invitation of H.E. Mr. Venkaiah Naidu, Chairman
New Delhi, Nov 6 (IANS) Hyderabad-based pharma major Bharat Biotech’s US partner Ocugen has sought the Emergency Use Authorisation (EUA) from the US FDA for Covaxin to be administered in children aged two to 18 years. Ocugen said that it has
Hyderabad, Nov 3 (IANS) The Hyderabad-based Bharat Biotech announced on Wednesday that the World Health Organisation (WHO) has franted Emergency Use Listing to India’s first indigenous Covid-19 vaccine Covaxin. Developed by Bharat Biotech in partnership with the Indian Council of Medical
New Delhi, Nov 2 (IANS) After Australia recognised Bharat Biotech’s Covaxin for allowing entry of travellers who had received the vaccine, five more countries on Monday recognised India’s vaccine certificate. These five countries recognised both Covaxin and Covishield. The Ministry of
Hyderabad, Oct 21 (IANS) Covid-19 vaccine Covaxin maker Bharat Biotech on Thursday said it was proud to contribute to India reaching the one billion-mark of Covid vaccinations. The Hyderabad-based vaccine maker said that reaching the one billion-mark in just nine-months is
Hyderabad, Aug 6 Amid concerns in some quarters about the safety of Covaxin, Bharat Biotech has clarified that its Covid-19 vaccine is totally safe and that it is following uncompromising policy on safety and quality. The Hyderabad-based company’s clarification came
 |
 |
 |
|---|---|---|
 |
 |
 |
 |
 |
 |
